Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

Author(s):: Wortman, B.G.; Astreinidou, E.; Laman, M.S.; Steen-Banasik, E.M. van der; Lutgens, L.C.H.W.; Westerveld, H.; Koppe, F.; Slot, A.; Berg, H.A. van den; Nowee, M.E.; Bijmolt, S.; Stam, T.C.; Zwanenburg, A.G.; Mens, J.W.M.; Jurgenliemk-Schulz, I.M.; Snyers, A.; Gillham, C.M.; Weidner, N.; Kommoss, S.; Vandecasteele, K.; Tomancova, V.; Creutzberg, C.L. (0000-0002-7008-4321); Nout, R.A.; PORTEC Study Grp

Published: 2021
Publication type: Article / Letter to editor

Date issued: 2021-02-01
Language: English
Publisher: Elsevier
Is part of: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2021), Vol. 155, p. 160-166
hdl: 1887/3280417
doi: 10.1016/j.radonc.2020.10.038
URL: https://www.sciencedirect.com/science/article/pii/S0167814020308859?via%3Dihub